Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2370 (opicapone) food-effect pharmacokinetic study in healthy Japanese males
jRCT2080223528Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of opicapone in Parkinson's disease (PD) (2 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Pharmacokinetic parameters of opicapone under fasted and fed conditions and Effect of food on opicapone pharmacokinetics. Started May 2017; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080223528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223528.